Emerging Treatments for Skin Cancer and Post Treatment Care
Skin cancer is one of the most common malignancies worldwide, encompassing melanoma and non-melanoma types such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). While early-stage disease is often curable with surgical excision, advanced or metastatic disease historically carried a poor prognosis. Recent years have seen a significant transformation in the treatment landscape. Immunotherapy—particularly immune checkpoint inhibitors—has revolutionised outcomes, especially in melanoma, by enhancing the body’s immune response against tumour cells.
.jpg)
Learning Outcomes
What you'll learn
- Describe the major types of skin cancer and their treatment pathways.
- Understand emerging therapies including immunotherapy and targeted therapy.
- Identify appropriate candidates for advanced treatments.
- Recognise treatment-related adverse effects and complications.
- Implement post-treatment monitoring and follow-up strategies.
- Provide patient education and preventive care to reduce recurrence risk.
Learning Outcomes
What you'll learn
- Describe the major types of skin cancer and their treatment pathways.
- Understand emerging therapies including immunotherapy and targeted therapy.
- Identify appropriate candidates for advanced treatments.
- Recognise treatment-related adverse effects and complications.
- Implement post-treatment monitoring and follow-up strategies.
- Provide patient education and preventive care to reduce recurrence risk.
Modules
Module 1
Overview of Skin Cancer and Traditional Treatments
Module 2
Immunotherapy in Skin Cancer
Module 3
Targeted Therapy and Precision Medicine
Module 4
Emerging and Future Therapies
Module 5
Post-Treatment Care and Monitoring
Module 6
Patient Education and Preventive Strategies
Module 7
Summary
Top reviews
No reviews yet.
You May Also Like
Come and Work
with Us!
Join us as a healthcare trainer providing practical sessions to professionals and workers.
Apply for Trainer RoleIn-Person Practical
Healthcare Training
Enroll in our accredited, hands-on practical training sessions to deliver better patientcentred care.
Apply for TrainingRefer &
Earn Rewards.
Invite healthcare professionals to join Care Learning and earn rewards for every successful referral.
Frequently Asked Questions
Immunotherapy, especially checkpoint inhibitors, has significantly improved outcomes.
Treatment that targets specific genetic mutations in cancer cells.
BRAF mutation.
Drugs that enable the immune system to attack cancer cells.
To detect recurrence and manage complications early.
Through sun protection and regular skin checks.


.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)



.jpg)